APOSCIENCE AG
Aposcience AG is a biopharmaceutical company established in 2008 and headquartered in Vienna.The company is developing innovative therapeutics for regenerative medicine that are based on secretomes of white blood cells isolated from peripheral blood. This approach sets Aposcience apart from the significant number of competitors working on stem cell based approaches. It is in tune with the generally accepted notion that stem cells exert their beneficial effects by paracrine signaling, not by rebuilding tissue per se. In contrast to competitors in the field, the company utilizes for APOSECTM production easily obtainable peripheral blood mononuclear cells as compared to stem cells or stem cell-derived secretomes from bone marrow.
APOSCIENCE AG
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.aposcience.at
Total Employee:
1+
Status:
Active
Contact:
+43 / (0)664 / 212 05 57
Technology used in webpage:
PHP Austrian Server Location
Similar Organizations
Agennix
Agennix is a biopharmaceutical company.
Anwita Biosciences
Anwita Biosciences is a biopharmaceutical company.
Apoteket AB
Apoteket AB is a state-owned pharmaceuticals retailer in Sweden.
AureoGen Biosciences
AureoGen Biosciences is a Pharmaceutical Company.
GeneOne Life Science
GeneOne Life Science is a biopharmaceutical R&D company.
Hovione
Hovione is a Pharmaceutical Company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
ProStrakan
ProStrakan is a pharmaceutical company.
SignaBlok
SignaBlok is a biopharmaceutical company.
Swedish Orphan Biovitrum
International Pharmaceutical Manufacture
Official Site Inspections
http://www.aposcience.at
- Host name: www84sni.world4you.com
- IP address: 81.19.159.84
- Location: Austria
- Latitude: 48.2
- Longitude: 16.3667
- Timezone: Europe/Vienna
More informations about "Aposcience AG"
Aposcience AG – the secretome company
Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high …See details»
Company – Aposcience AG
Aposcience AG is a biopharmaceutical company established in 2008 and headquartered in Vienna. The company is developing innovative therapeutics for regenerative medicine that are …See details»
Management – Aposcience AG
Michael Mildner (Chief Scientific Officer (CSO)) is associated professor at the Department of Dermatology, Medical University of Vienna with long lasting experience in skin biology and cutaneous tissue regeneration. He received his …See details»
Aposcience AG - Crunchbase Company Profile & Funding
Aposcience AG is a biopharmaceutical company established in 2008 and headquartered in Vienna.The company is developing innovative therapeutics for regenerative medicine that are …See details»
Life Sciences Directory: Aposcience AG
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna Focus human health Profile. Aposcience AG is unique in having developed a secretome-based regenerative …See details»
Aposcience - Products, Competitors, Financials, Employees, …
Aposcience's therapies target conditions such as diabetic ulcers, deep skin burns, myocardial infarction, stroke, and spinal cord injuries. It was founded in 2006 and is based in Vienna, …See details»
Aposcience AG - ADVANTAGE AUSTRIA
Aposcience is a spin-off from the Medical University Vienna and develops first-in-class therapeutics targeting the cell regeneration process. Industry Health Infrastructure & …See details»
Aposcience AG: Drug pipelines, Patents, Clinical trials - Synapse
Jun 21, 2023 Explore Aposcience AG with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Disease Domain:Nervous System Diseases, Endocrinology and …See details»
Aposcience AG | European Clinical Trials Information Network
In 2014, Aposcience AG merged with another biotech company, BioTissue Technologies, to expand its expertise in the field of tissue engineering. This merger allowed the company to …See details»
Aposcience AG Company Profile | Wien, Wien, Austria
Find company research, competitor information, contact details & financial data for Aposcience AG of Wien, Wien. Get the latest business insights from Dun & Bradstreet.See details»
Aposcience AG - LinkedIn
Aposcience AG aspires to improve the health of patients in need of regenerative medicine by commercially exploiting the therapeutic potential of secretomes derived from white blood cells …See details»
Aposcience Company Profile - Office Locations, Competitors
Aposcience is a company that operates in the field of regenerative medicine. Its technology is based on the secretomes of white blood cells (peripheral blood mononuclear cells). The …See details»
Aposcience AG - Manufacture Of Peripheral White Blood Cells
Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for dis... Aposcience AG - …See details»
Viral safety of APOSECTM: a novel peripheral blood mononuclear …
The MB/light treatment (commercially available as THERAFLEX MB-Plasma system) is one of the virus inactivation methods recommended by the World Health Organization 1. The system …See details»
Mission Statement – Aposcience AG
Aposcience AG aspires to improve the health of patients in need of regenerative medicine by commercially exploiting the therapeutic potential of secretomes derived from white blood cells …See details»
APOSCIENCE AG completes secretome-based Phase I trial in
Oct 15, 2021 Aposcience AG evolved as a „spin off“ of the Clinical Department of Surgery of the Medical University of Vienna. The close cooperation between Aposcience AG and the Medical …See details»
Overview – Aposcience AG
Peripheral white blood cells (PBMCs) PBMCs driven into apoptosis through cellular stress have been shown to be highly potent in experimental wound healing, stroke, spinal cord injury, …See details»
Peripheral white blood cell therapeutics - Aposcience
06 Dec 2023 Aposcience completes phase I/II trials in Diabetic Foot ulcers in Austria, Germany, Poland, Czech Republic (NCT04277598) (EudraCT2018-001653-27) ... If your organization …See details»
Clinical – Aposcience AG
Aposcience AG will initiate a program to demonstrate safety and efficacy in this important indication with very large unmet medical need. The program consists of a phase I study in …See details»
Technology – Aposcience AG
Aposcience AG scientists have made the seminal observation that a complex mixture of cytokines, growth factors, lipids and exosomes are released from peripheral white blood cells …See details»